Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.
about
Zosteriform impetigo: Wolf's isotopic response in a cutaneous immunocompromised districtA molecular modeling based screening for potential inhibitors to alpha hemolysin from Staphylococcus aureusA study of the prevalence of methicillin-resistant Staphylococcus aureus in dermatology inpatientsNVC-422 topical gel for the treatment of impetigo.In vitro bactericidal activity of Streptococcus pneumoniae and bactericidal susceptibility of Staphylococcus aureus strains isolated from cocolonized versus noncocolonized childrenStatus Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, CommonlyGuidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.Antibiotic resistance in Staphylococcus aureus-containing cutaneous abscesses of patients with HIV.Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.The clinical spectrum and antibiotic sensitivity patterns of staphylococcal pyodermas in the community and hospital.Cellulitis: diagnosis and management.Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus.Cutaneous Immune Defenses Against Staphylococcus aureus Infections.Bone and Joint Infections in Children: Septic Arthritis.New and emerging concepts in managing and preventing community-associated methicillin-resistant Staphylococcus aureus infections.Update on management of skin and soft tissue infections in the emergency department.Unusual presentation of cactus spines in the flank of an elderly man: a case report.[Skin infections with MRSA. Epidemiology and clinical features].Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.Using focus groups to revise an educational booklet for people living with methicillin-resistant Staphylococcus aureus (MRSA).Hospital admissions for skin infections among Western Australian children and adolescents from 1996 to 2012.Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study.
P2860
Q26785959-261A09A9-8F5A-4892-9102-D5B2AE2BB6AAQ33426334-F7F94BA3-51CD-458D-B76F-EAB9FEC79C18Q34494955-1545AFFB-296E-414F-8A9D-C12CFA1EC8D5Q35178191-9F51E58B-EA77-47F6-9609-704421613175Q36452625-1F5E84BF-521B-4B38-90BF-F12FBBE6D31BQ37055233-18F639AE-E582-43A0-B4A7-B7A1B034E5B1Q37109817-7FEF9CFE-DC56-4231-8244-E5B37C2DC9BCQ37345178-AF9D634D-8AF2-4C83-8E97-AD03BDCAB5C7Q37650812-BEFD06C0-6E8C-4EE9-982A-CD9F7F68FA7DQ37672194-EA6AE34D-1105-4208-8177-B67DCF72589BQ37853602-28C41A48-ED17-4503-8CE3-6F9543E14799Q37853607-C4521BF4-FD7C-4CBA-BE1F-8C52DDCA6D58Q38524810-E0FE45A5-D115-40AA-A53B-2C94C7FAB452Q38550283-41308F86-CCB7-4F99-B635-CC7F53BB5D8FQ38558047-A05A84D6-84A4-4B1C-8798-249A7F8F844EQ39165124-4E17EC1E-F7FA-44F2-84A9-C627508F7319Q41087202-2606EE17-674D-4DB8-BD7F-D9C22D652B72Q44542229-E5CBC50B-F818-4458-877F-98897B586D3CQ46620675-51C35BFA-0D6F-413C-A08F-62AA208AAB6EQ46827350-E3BF95DD-D9B7-45E2-A994-53409BA13055Q47141297-62D4A3BA-8C35-4F58-8499-47B6826DDB3CQ54372246-67ACEA13-CD37-4898-BF44-27A8002DC748
P2860
Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Community-acquired methicillin ...... s, management, and prevention.
@ast
Community-acquired methicillin ...... s, management, and prevention.
@en
type
label
Community-acquired methicillin ...... s, management, and prevention.
@ast
Community-acquired methicillin ...... s, management, and prevention.
@en
prefLabel
Community-acquired methicillin ...... s, management, and prevention.
@ast
Community-acquired methicillin ...... s, management, and prevention.
@en
P2860
P1476
Community-acquired methicillin ...... s, management, and prevention.
@en
P2093
Philip R Cohen
P2860
P356
10.1111/J.1365-4632.2007.03215.X
P577
2007-01-01T00:00:00Z